Insulin aspart, recombinant Subcutaneous and Telavancin Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Telavancin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: telavancin
Brand name: Vibativ
Synonyms: Telavancin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Telbivudine
- Insulin aspart, recombinant Subcutaneous-Telbivudine Tablets
- Insulin aspart, recombinant Subcutaneous-Telithromycin
- Insulin aspart, recombinant Subcutaneous-Telmisartan
- Insulin aspart, recombinant Subcutaneous-Telmisartan and Amlodipine
- Insulin aspart, recombinant Subcutaneous-Telmisartan and Hydrochlorothiazide
- Telavancin Intravenous-Insulin degludec
- Telavancin Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Telavancin Intravenous-Insulin Degludec (U-100) Vials
- Telavancin Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Telavancin Intravenous-Insulin degludec and liraglutide
- Telavancin Intravenous-Insulin degludec and liraglutide Subcutaneous